Irwin Naturals (FRA:97X) Debt-to-Equity : 5.69 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Irwin Naturals Debt-to-Equity?

Irwin Naturals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €31.02 Mil. Irwin Naturals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €7.11 Mil. Irwin Naturals's Total Stockholders Equity for the quarter that ended in Sep. 2023 was €6.70 Mil. Irwin Naturals's debt to equity for the quarter that ended in Sep. 2023 was 5.69.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Irwin Naturals's Debt-to-Equity or its related term are showing as below:

FRA:97X' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.25 Med: 0.63 Max: 5.69
Current: 5.69

During the past 3 years, the highest Debt-to-Equity Ratio of Irwin Naturals was 5.69. The lowest was 0.25. And the median was 0.63.

FRA:97X's Debt-to-Equity is ranked worse than
97.45% of 549 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs FRA:97X: 5.69

Irwin Naturals Debt-to-Equity Historical Data

The historical data trend for Irwin Naturals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Irwin Naturals Debt-to-Equity Chart

Irwin Naturals Annual Data

Trend

Dec20

Dec21

Dec22

Debt-to-Equity

0.65

0.57

0.92

Irwin Naturals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial									0.63	0.92	2.70	3.82	5.69

Competitive Comparison of Irwin Naturals's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Irwin Naturals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Irwin Naturals's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Irwin Naturals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Irwin Naturals's Debt-to-Equity falls into.

Irwin Naturals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Irwin Naturals's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(17.276	+	2.857)	/	21.897
	=	0.92

Irwin Naturals's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.024	+	7.111)	/	6.703
	=	5.69

Irwin Naturals (FRA:97X) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Irwin Naturals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Irwin Naturals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Irwin Naturals (FRA:97X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Irwin Naturals Inc (FRA:97X) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

IWINF:USA IWIN:Canada

Address

5310 Beethoven Street, Los Angeles, CA, USA, 90066

Website

https://www.irwinnaturals.com

Irwin Naturals Inc develops vitamins and other health supplements and distributes these products in the United States and Canada through two main channels: health food stores and mass market retailers. The company has three operating segments namely Products; Clinics and Corporate. It generates maximum revenue from the Products segment.

Irwin Naturals (FRA:97X) Headlines

No Headlines